Article
Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.
Journal of viral hepatitis - 1 Mar 2016
Visvanathan K, Lang T, Ryan K, Wilson R, Skinner N A, Thompson A J V, Ahn S H, Weilert F, Abbott W, Gane E, Colledge D, Li K, Locarnini S, Mansell A, Revill P A
Abstract excerpt
Patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) have suppressed TLR2 expression, function and cytokine production. The aim of this study was to explore the importance of hepatitis B virus (HBV) genotype in innate immune responses and investigate whether Toll-like receptor (TLR) expression/function has potential roles as predictive biomarkers of successful therapy with pegylated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
